ST2 is a risk marker of therapy-resistant graft-vs-host disease and death

This week's issue of the New England Journal of Medicine investigates ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

http://www.gastrohep.com/news/news.asp?id=109818